Nebraska Revised Statutes Chapter 44. Insurance § 44-7,124. Biomarker testing; covered by medical assistance program; when

(i) The diagnosis, treatment, appropriate management, or ongoing monitoring of cancer, an autoimmune or autoinflammatory disease, Parkinson's disease, amyotrophic lateral sclerosis, Alzheimer's disease and related dementias, rheumatoid arthritis, preeclampsia, sickle cell anemia, or a cardiovascular condition;

(ii) An organ or tissue transplant; or

(iii) Pharmacogenomic testing; and

(i) Labeled indications for a test approved or cleared by the federal Food and Drug Administration;

(ii) Indicated tests for a drug approved by the federal Food and Drug Administration;

(iii) Warnings and precautions on drug labels approved by the federal Food and Drug Administration;

(iv) National coverage determinations by the federal Centers for Medicare and Medicaid Services or local coverage determinations by the medicare administrative contractor; or

(v) Nationally recognized clinical practice guidelines and consensus statements.